Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Tackling obesity: lessons from genetics

      ea0029eje1
    • The European Journal of Endocrinology Prize Winner

      ea0029eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Glucocorticoid metabolism and the brain, from fetal programming to senescence

      ea0029gh1
    • The Geoffrey Harris Prize Winner

      ea0029gh1biog
  • The Fondation IPSEN Prize Lecture
  • • Common Threads: Epigenetics, Metabolism and the Clock

      ea0029ifpl1
    • The Fondation IPSEN Prize Winner

      ea0029ifpl1biog
• Plenary Lectures
• • Red wine Endocrinology
  • • New insights into the roles of sirtuins in metabolic decline and disease of aging

      ea0029pl1
  • Testosterone more than sex
  • • Testosterone: more than sex

      ea0029pl2
  • Mating, sex and the immune system in humans and fish
  • • Mating, sex and the immune system in humans and fish.

      ea0029pl3
  • Lecture by Endocrine Society President
  • • Abstract unavailable

      ea0029pl4
  • Why your bones break - from childhood to old age
  • • Why your bones break: from childhood to old age

      ea0029pl5
  • Maternal nutrition, metabolism and fetal programming
  • • Abstract unavailable

      ea0029pl6
  • Diabetes as a gut disease
  • • Diabetes as a gut disease

      ea0029pl7
  • Novel molecular link between the circadian clock and hypertension
  • • Novel molecular link between the circadian clock and hypertension

      ea0029pl8
• Symposia
• • Molecular mechanisms of differentiated thyroid cancer
  • • Molecular consequences of deregulated RNA genes in papillary thyroid carcinoma

      ea0029s1.1
    • Correlation between the BRAF V600E mutation, TGF[beta] pathway and tumour invasiveness in papillary thyroid carcinomas

      ea0029s1.2
    • Abstract unavailable

      ea0029s1.3
  • 40 years of male hormonal contraception research and no product
  • • Abstract unavailable

      ea0029s2.1
    • Clinical trials in male hormonal contraception to date

      ea0029s2.2
    • Acceptability of male hormonal contraception by the pharmaceutical industry and by the consumer

      ea0029s2.3
  • Absolute fracture risk assessment with FRAX
  • • Abstract unavailable

      ea0029s3.1
    • Use of FRAX in Asian populations

      ea0029s3.2
    • Beyond FRAX[Ograve]

      ea0029s3.3
  • The gut nutrient sensing in energy metabolism
  • • Bile acid metabolism for the control of metabolic disease

      ea0029s4.1
    • Taste receptors in gut regulate endocrine function

      ea0029s4.2
    • Gut microbiome and energy metabolism: the concept of MicrObesity

      ea0029s4.3
  • Transition from paediatric to adult care - do we have progress?
  • • GH use in Prader-Willi syndrome (PWS): an evidence-based approach to a clinical practice guideline (CPG), on behalf of the GH Research Society (GRS) and Workshop Participants

      ea0029s5.1
    • Fertility options for adults with panhypopituitarism

      ea0029s5.2
    • Sex steroid replacement in young males and females

      ea0029s5.3
  • Subclinical adrenal diseases
  • • Diagnosis and treatment of subclinical Cushing's syndrome (SCS)

      ea0029s6.1
    • Abstract unavailable

      ea0029s6.2
    • Subclinical Addison's disease

      ea0029s6.3
  • Hormones, metabolism and cancer: more than coincidences?
  • • An epigenetic switch linking inflammation to cancer and the use of metformin as an anti-cancer drug

      ea0029s7.1
    • The insulin-like growth factor system and cancer: what are the implications?

      ea0029s7.2
    • Obesity and cancer

      ea0029s7.3
  • Global phenotypes of endocrine disease
  • • Abstract unavailable

      ea0029s8.1
    • Ethnic specific PCOS

      ea0029s8.2
    • Obesity and diabetes in Asian Indians

      ea0029s8.3
  • The risk and benefits of tight glycaemic control
  • • What do type 2 diabetes outcome trials tell us about the CV risks and benefits of intensive glycaemic control

      ea0029s9.1
    • Abstract unavailable

      ea0029s9.2
    • Time course of the glucose legacy effect

      ea0029s9.3
  • Thyroid: From fetal life to adulthood
  • • Placental transport of thyroid hormone

      ea0029s10.1
    • Abstract unavailable

      ea0029s10.2
    • Thyroid hormones and fetal neurological development

      ea0029s10.3
  • Novel genetic and endocrine insights in the Klinefelter's syndrome
  • • Klinefelter mouse (41XXY): model for human Klinefelter syndrome

      ea0029s11.1
    • Endocrine changes in KS and the effects on growth, bone and body composition

      ea0029s11.2
    • The Muenster EXAKT project: epigenetic regulation of the supernumerary X chromosome and its escapee genes

      ea0029s11.3
  • Determinants of peak bone mass
  • • Epidemiology of peak bone mass, structure and strength in males as assessed by high resolution peripheral quantitative CT (HR-pQCT). A cross-sectional study

      ea0029s12.1
    • The contribution of genetic factors to bone mass

      ea0029s12.2
    • Estrogens as regulators of bone growth and bone mass

      ea0029s12.3
  • Novel therapies for protecting beta cell function at diagnosis of type 1 diabetes
  • • Abstract unavailable

      ea0029s13.1
    • Abstract unavailable

      ea0029s13.2
    • Abstract unavailable

      ea0029s13.3
  • Wnt/Beta-catenin in pituitary development and disease
  • • [beta]-catenin deficiency disrupts patterning of the ventral diencephalon, causing adenohypophysis over growth and dysmorphology

      ea0029s14.1
    • Wnt/beta-catenin signalling in craniopharyngioma

      ea0029s14.2
    • Wnt signalling in oestrogen-induced lactotroph proliferation

      ea0029s14.3
  • Adrenal cancer
  • • Molecular pathogenesis of adrenocortical cancer

      ea0029s15.1
    • Imaging of adrenocortical cancer

      ea0029s15.2
    • Genetics of micronodular hyperplasias (associated with Cushing syndrome)

      ea0029s15.3
  • Understanding growth
  • • From Galton to GWAS (and beyond): what we have learned about the genetics of human height?

      ea0029s16.1
    • Genes and the investigation of idiopathic short stature (ISS): are we ready for prime time?

      ea0029s16.2
    • Abstract unavailable

      ea0029s16.3
  • Hormonal control of pregnancy
  • • Hormone signalling between mother and fetus

      ea0029s17.1
    • What controls labour in humans?

      ea0029s17.2
    • Placental hormones as putative markers of gestational diseases

      ea0029s17.3
  • Molecular mechanisms in autoimmune thyroid disease
  • • Predictors of relapse of Graves' disease after antithyroid drug withdrawal

      ea0029s18.1
    • Genotype-phenotype correlations in GD

      ea0029s18.2
    • Regulatory cells, Th17 lymphocytes, and dendritic cells in autoimmune thyroid disease

      ea0029s18.3
  • Controversies in testosterone replacement
  • • Abstract unavailable

      ea0029s19.1
    • Late onset hypogonadism: who should receive testosterone?

      ea0029s19.2
    • Testosterone for women: why when and how?

      ea0029s19.3
  • Signalling to and from osteoclast
  • • Efferent signalling by osteoclasts

      ea0029s20.1
    • Immune signaling in osoteoclasts

      ea0029s20.2
    • Coupling of bone resorption and formation

      ea0029s20.3
  • Obesity and reproduction
  • • Integrating hypothalamic regulation of energy homeostasis and reproduction

      ea0029s21.1
    • Impact of obesity on male reproduction

      ea0029s21.2
    • Lifestyle modification and fertility

      ea0029s21.3
  • Pituitary tumorigenesis
  • • Molecular mechanisms: the genes involved in pituitary tumorigenesis

      ea0029s22.1
    • Tracing back a Gene's influence

      ea0029s22.2
    • Abstract unavailable

      ea0029s22.3
  • Advances in regulation of aldosterone synthesis
  • • Regulation of aldosterone synthase expression in normal adrenal and primary aldosteronism

      ea0029s23.1
    • Extra-adrenal aldosterone biosynthesis

      ea0029s23.2
    • Role of N-type calcium channel blockers in aldosterone biosynthesis

      ea0029s23.3
  • ManagemDiabetes in children
  • • Abstract unavailable

      ea0029s24.1
    • Hypotheses explaining the increase in type 1 diabetes

      ea0029s24.2
    • Abstract unavailable

      ea0029s24.3
  • Reproductive hormone action
  • • GnRH receptor signalling

      ea0029s25.1
    • Light on the structural communication in gonadotropin hormone receptors: implications in genetic diseases

      ea0029s25.2
    • Extragonadal FSH action- facts and dreams

      ea0029s25.3
  • TSH Receptor
  • • Low molecular weight antagonists of the TSH receptor

      ea0029s26.1
    • Learning from how antibodies interact with the TSH receptor

      ea0029s26.2
    • Structure and function of TSH receptor

      ea0029s26.3
  • Are endogenous testosterone levels predictors of cardiovascular events?
  • • Androgen action on the cardiovascular system

      ea0029s27.1
    • Abstract unavailable

      ea0029s27.2
    • Endogenous androgens, diabetes, and cardiovascular disease in women: the Rancho Bernardo study

      ea0029s27.3
  • Osteoporosis treatment in 2012 and beyond
  • • Controversial issues with bisphosphonate treatment

      ea0029s28.1
    • Sclerostin: a key bone regulatory molecule

      ea0029s28.2
    • Other emerging therapies

      ea0029s28.3
  • Are we ready for novel therapies in obesity?
  • • Abstract unavailable

      ea0029s29.1
    • Growth hormone replacement and metabolic syndrome in GH deficient adults

      ea0029s29.2
    • GLP-1 and analogues in obesity

      ea0029s29.3
  • New developments in pituitary adenomas
  • • Symposium 30: new developments in pituitary adenoma cytokines and other new genes in pituitary adenomas

      ea0029s30.1
    • 'Dopastatin': an evolving story

      ea0029s30.2
    • The use of temozolomide in pituitary tumours

      ea0029s30.3
  • Progress in treatment in primary aldosteronism
  • • Abstract unavailable

      ea0029s31.1
    • Abstract unavailable

      ea0029s31.2
    • Abstract unavailable

      ea0029s31.3
  • Disorders of sex development (DSD)
  • • Genetics of disorders of sex development

      ea0029s32.1
    • Psychosocial and psychosexual outcome in DSD

      ea0029s32.2
    • Abstract unavailable

      ea0029s32.3
  • Pollution Related Acromegaly
  • • Pollution mediated acromegaly

      ea0029s33.1
    • Exposure to endocrine disrupting chemicals may interfere with reproductive development in humans and affect timing of puberty

      ea0029s33.2
    • Effect of iodine intake on thyroid diseases in China

      ea0029s33.3
  • Effects of thyroid hormone derivatives
  • • Pathways of thyroid hormone (TH) metabolism

      ea0029s34.1
    • Thyroid hormone mimetic compounds

      ea0029s34.2
    • Abstract unavailable

      ea0029s34.3
  • Endocrinology and the Olympics: Will hormones help to win?
  • • Does the high performance athlete need hormone replacement?

      ea0029s35.1
    • Can an endocrine patient participate in high performance sports?

      ea0029s35.2
    • Hormone abuse in sports: the knowns and unknowns

      ea0029s35.3
  • Bone and metabolism
  • • Leptin and bone signaling

      ea0029s36.1
    • Insulin-bone axis

      ea0029s36.2
    • Functions and mode of action of osteocalcin

      ea0029s36.3
  • Diabetes and cancer
  • • Abstract unavailable

      ea0029s37.1
    • Abstract unavailable

      ea0029s37.2
    • Goiter throughout the pediatric ages

      ea0029s37.3
  • Craniopharyngioma: Hypothalamic complications
  • • Childhood Craniopharyngioma

      ea0029s38.1
    • Hypothalamic disorders in Clinical practice; relevance to clinical practice

      ea0029s38.2
    • Management of hypothalamic obesity in patients with craniopharyngioma

      ea0029s38.3
  • Adrenal insufficiency
  • • Abstract unavailable

      ea0029s39.1
    • Molecular pathomechanisms of steroidogenetic adrenal disorders

      ea0029s39.2
    • New developments in the immunology of Addison's disease

      ea0029s39.3
  • New familial endocrine cancer syndromes: pathophysiology and counselling
  • • DICER1 mutations characterize a novel syndrome with endocrine features

      ea0029s40.1
    • The paediatric patient with paraganglioma syndrome

      ea0029s40.2
    • Li-Fraumeni Syndrome: A paradigm of genetic testing to clinical surveillance for pediatric endocrine tumors

      ea0029s40.3
  • The endocrinology of adipose tissue
  • • Physiological and neuronal determinants of brown adipose tissue-mediated thermogenesis in small mammals and humans

      ea0029s41.1
    • 'Obesity and insulin resistance: the cross-talk macrophage-adipocyte view'

      ea0029s41.2
    • Abstract unavailable

      ea0029s41.3
  • Novel insights into regulation of puberty
  • • Central networks controlling the timing of puberty

      ea0029s42.1
    • Re-wiring the hypothalamus with new peptides to control puberty

      ea0029s42.2
    • Novel insights into regulation of puberty: lessons from human genetics

      ea0029s42.3
  • Graves' orbitopathy (GO)
  • • Immunopathogenesis of Graves' orbitopathy

      ea0029s43.1
    • How to restore euthyroidism in the presence of Graves' orbitopathy? Is there a best way?

      ea0029s43.2
    • Progress in immunosuppressive treatment of GO (selenium, steroid dosage, rituximab)

      ea0029s43.3
  • Genome wide studies in reproduction
  • • Genome-wide association study of endometriosis identifies a locus at 7p15.2 with pleiotropic effects

      ea0029s44.1
    • Cytogenetic analysis and genome-wide association study (GWAS) in chinese women with premature ovarian failure (POF)

      ea0029s44.2
    • Genetics of (In)fertility

      ea0029s44.3
  • Bone quality and bone strength
  • • Abstract unavailable

      ea0029s45.1
    • Finite element analysis in osteology

      ea0029s45.2
    • Abstract unavailable

      ea0029s45.3
  • Chronic inflammation and insulin resistance
  • • AIMing at metabolic syndrome: towards development of novel therapies for modern metabolic diseases via macrophage-derived AIM

      ea0029s46.1
    • Macrophage regulation of adipocyte biology

      ea0029s46.2
    • The inflammatory-adipokine hypothesis and stem cell abnormalities

      ea0029s46.3
  • Cushing's syndrome
  • • Abstract unavailable

      ea0029s47.1
    • Abstract unavailable

      ea0029s47.2
    • Learnings from ERCUSYN: the first 500 patients

      ea0029s47.3
  • Pathogenesis of primary aldosteronism
  • • Genomic profile in primary aldosteronism

      ea0029s48.1
    • Integrating genetics and genomics in primary aldosteronism

      ea0029s48.2
    • Potassium channels in primary aldosteronism

      ea0029s48.3
  • Genetic breakthroughs in reproductive pathology and physiology
  • • Abstract unavailable

      ea0029s49.1
    • Abstract unavailable

      ea0029s49.2
    • RANK ligand mediates hormone induced mammary epithelial proliferation and carcinogenesis

      ea0029s49.3
  • Circadian regulation of metabolism
  • • Basic mechanisms of circadian regulation in the brain

      ea0029s50.1
    • Abstract unavailable

      ea0029s50.2
    • Circadian rhythms in adipose tissue

      ea0029s50.3
  • Recent management of pheochromocytoma/paraganglioma syndrome
  • • Recent progress in biochemical testing for pheochromocytoma

      ea0029s51.1
    • Prevalence of SDH gene mutations in pheochromocytoma

      ea0029s51.2
    • Treatment of malignant pheochromocytoma

      ea0029s51.3
  • Thyroid & Pregnancy
  • • Outcome of the controlled antenatal thyroid screening study

      ea0029s52.1
    • The case for thyroid screen in pregnancy

      ea0029s52.2
    • Treatment of hyperthyroidism in pregnancy

      ea0029s52.3
  • Genetic polymorphism in reproduction
  • • Genetic variation of the androgen receptor: from gene regulation to prostate cancer

      ea0029s53.1
    • Abstract unavailable

      ea0029s53.2
    • Genetic complexity of FSH receptor function

      ea0029s53.3
  • Vitamin D
  • • Vitamin D is a multifunctional hormone Roger Bouillon Clinic and laboratory of experimental medicine and endocrinology

      ea0029s54.1
    • Vitamin D and primary hyperparathyroidism

      ea0029s54.2
    • Abstract unavailable

      ea0029s54.3
  • The fatty liver as an endocrine disease
  • • Pathogenesis of fatty liver disease

      ea0029s55.1
    • Abstract unavailable

      ea0029s55.2
    • Fatty liver disease in childhood

      ea0029s55.3
  • Pituitary development transcription factors: stem cells and beyond
  • • The GPS niche of stem cells in the pituitary

      ea0029s56.1
    • LHX3: an insightful model of pituitary hormone deficiency

      ea0029s56.2
    • Transcriptional and epigenetic mechanisms for cell fate choice in pituitary

      ea0029s56.3
  • What's new in congenital adrenal hyperplasia (CAH)?
  • • Congenital adrenal hyperplasia: counselling from birth to the next generation

      ea0029s57.1
    • CAH and adulthood

      ea0029s57.2
    • Abstract unavailable

      ea0029s57.3
  • Best Clinical Practice
  • • Towards a European Guideline for the treatment of hyponatremia

      ea0029s58.1
    • Abstract unavailable

      ea0029s58.2
    • Abstract unavailable

      ea0029s58.3
  • Obesity and thyroid function
  • • Obesity and thyroid function

      ea0029s59.1
    • Abstract unavailable

      ea0029s59.2
    • Type 2 deiodinase in muscle during health and disease

      ea0029s59.3
  • Performance enhancing hormones in sports
  • • The spectrum of hormones in sports doping

      ea0029s60.1
    • GH and testosterone: do they work?

      ea0029s60.2
    • Erythropoietin and its derivatives

      ea0029s60.3
  • New insights in thyroid cancer diagnosis
  • • BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status

      ea0029s61.1
    • Abstract unavailable

      ea0029s61.2
    • Abstract unavailable

      ea0029s61.3
  • Early Development and Treatment of PCOS
  • • Early hormonal abnormalities in children born to women with PCOS

      ea0029s62.1
    • Early development and pubertal prevention of polycystic ovary syndrome

      ea0029s62.2
    • Hyperandrogenism in obese girls: what is the significance?

      ea0029s62.3
  • Emerging ideas about phosphate metabolism
  • • Abstract unavailable

      ea0029s63.1
    • FGF23 and tumor-induced osteomalacia

      ea0029s63.2
    • FGF23 in chronic renal failure

      ea0029s63.3
  • Endoplasmic Reticulum Stress, Obesity and Metabolic Homeostasis
  • • Abstract unavailable

      ea0029s64.1
    • Abstract unavailable

      ea0029s64.2
    • Abstract unavailable

      ea0029s64.3
  • Somatostatin receptors in pituitary
  • • Imaging somatostatin activity in live pituitary

      ea0029s65.1
    • Is somatostatin receptor expression in adenomas related to pharmacological response?

      ea0029s65.2
    • Somatostatin receptors and filamin: a developing story

      ea0029s65.3
  • HPA axis, stress metabolism and adaptation
  • • Neuroendocrine and (epi)genetic impact on HPA function

      ea0029s66.1
    • Abstract unavailable

      ea0029s66.2
    • Modulation of cortisol action

      ea0029s66.3
  • Central regulation of energy homeostasis
  • • CNS control of energy and glucose metabolism

      ea0029s67.1
    • Gut hormones: history, physiology and therapeutic opportunities

      ea0029s67.2
    • Abstract unavailable

      ea0029s67.3
  • European network for the study of adrenal tumours (ENSAT)
  • • Genetics for pheochromocytoma and paraganglioma in 2012

      ea0029s68.1
    • Abstract unavailable

      ea0029s68.2
    • Abstract unavailable

      ea0029s68.3
  • Current progress in the management of thyroid cancer
  • • TSH suppression in differentiated thyroid cancer: how low should we go?

      ea0029s69.1
    • Abstract unavailable

      ea0029s69.2
    • Abstract unavailable

      ea0029s69.3
  • Young Active Researchers Symposium (YAR)
  • • New mechanisms underlying the role of the mTORC1 pathway in the hypothalamic control of energy balance

      ea0029s70.1
    • Abstract unavailable

      ea0029s70.2
    • DNA methylation of the body weight-regulating proopiomelanocortin gene: functional and ontogenetic aspects

      ea0029s70.3
    • Mineralocorticoid receptor antagonism counters metabolic dysfunctions induced by high fat diet in mice

      ea0029s70.4
    • A four-week fat overfeeding study in constitutional thin women: a human model of weight gain resistance

      ea0029s70.5
• Endocrine Nurse Symposium
• • (1)
  • • Puberty induction in males and females

      ea0029en1.1
    • The role of the endocrine nurse in puberty induction

      ea0029en1.2
    • Abstract unavailable

      ea0029en1.3
    • Choosing the right sex steroid replacement option for patients: the role of the endocrine nurse

      ea0029en1.4
    • Diagnosis and management of Cushing's syndrome

      ea0029en2.1
    • The role of the endocrine nurse in the diagnosis and management of the patient with Cushing's syndrome

      ea0029en2.2
    • Diagnosis and management of prolactinoma

      ea0029en2.3
    • Abstract unavailable

      ea0029en2.4
    • Abstract unavailable

      ea0029en3.1
    • The role of nurse prescribing in the care of endocrine patients

      ea0029en3.2
• JOE/JME Prize Presentation Sponsored by <emphasis role="italic">Journal of Endocrinology</emphasis>
• • (1)
  • • Melanocortin receptor accessory proteins (MRAPs) in adrenal gland physiology and beyond

      ea0029jp1
• Meet the Expert Sessions
• • (1)
  • • Adrenal incidentaloma and subclinical Cushing's syndrome

      ea0029mte1
    • Approach to the patient with Cushing's disease after pituitary surgery failure

      ea0029mte2
    • Abstract unavailable

      ea0029mte3
    • Challenges of transsphenoidal pituitary surgery

      ea0029mte4
    • Meet the expert: discussion of common but difficult thyroid cancer cases

      ea0029mte5
    • Clinical management of adrenocortical carcinoma

      ea0029mte6
    • Pregnancy and pituitary disorders

      ea0029mte7
    • Abstract unavailable

      ea0029mte8
    • Diagnosis and management of SIADH

      ea0029mte9
    • Elastosonography in the evaluation of thyroid and parathyroid lesions

      ea0029mte10
    • Diagnosis and treatment considerations in autoimmune polyendocrine syndrome type 1

      ea0029mte11
    • Abstract unavailable

      ea0029mte12
    • Graves' ophthalmopathy

      ea0029mte13
    • Hirsutism

      ea0029mte14
    • Pituitary tumours in adolescents and adults

      ea0029mte15
    • Management of non-functioning pituitary adenomas

      ea0029mte16
    • Multiple endocrine neoplasia type 2

      ea0029mte17
    • Normocalcemic primary hyperparathyroidism

      ea0029mte18
    • Abstract unavailable

      ea0029mte19
    • The diagnosis and treatment of secondary osteoporosis in children

      ea0029mte20
    • Autoimmune hyperthyroidism: initiation and duration of thionamide therapy

      ea0029mte21
    • Clinical management in transgender sex hormone treatment

      ea0029mte22
    • Subclinical hypothyroidism

      ea0029mte23
    • Approach to the management of the infertile couple

      ea0029mte24
    • Pituitary incidentalomas

      ea0029mte25
    • Abstract unavailable

      ea0029mte26
    • Differential diagnosis of Cushing's syndrome

      ea0029mte27
    • Abstract unavailable

      ea0029mte28
    • Management of bone loss induced by cancer treatment in early breast and prostate cancer

      ea0029mte29
    • Treatment of vitamin D deficiency

      ea0029mte30
    • Cryptorchidism

      ea0029mte31
    • Management of GEP-NET tumors

      ea0029mte32
• Oral Communications
• • Pituitary Clinical I
  • • Pasireotide LAR is significantly more effective than octreotide LAR at inducing biochemical control in patients with acromegaly: results of a 12-month randomized, double-blind, multicenter, Phase III study

      ea0029oc1.1
    • Patients with Cushing's disease achieve normal urinary cortisol with LCI699, a potent 11[beta]-hydroxylase inhibitor: preliminary results from a multicenter, proof-of-concept study

      ea0029oc1.2
    • Efficacy and safety of long-term treatment with pegvisomant in acromegaly: Italian pegvisomant observational study (ACROSTUDY)

      ea0029oc1.3
    • A multi-centre audit of the prevalence of cardiac valvulopathy in patients treated with dopamine agonists for hyperprolactinaemia

      ea0029oc1.4
    • Initial hypothalamic involvement is the major risk factor for impaired prognosis and quality of life in childhood craniopharyngioma regardless of chosen treatment strategies: results of KRANIOPHARYNGEOM 2000

      ea0029oc1.5
    • Normal weight adult patients with Prader-Willi syndrome are not protected from insulin resistance during treatment with GH: results from a 12 month prospective study

      ea0029oc1.6
  • Thyroid Clinical I
  • • Overt hyperthyroidism is associated with increased mortality: a nationwide register-based study of disease discordant Danish twins

      ea0029oc2.1
    • Identification and functional analysis of DUOX2 variants: biallelic mutations are associated with permanent congenital hypothyroidism

      ea0029oc2.2
    • Thyroid hormone levels in euthyroid young men are associated with body composition and metabolic parameters

      ea0029oc2.3
    • The thyroid hormone receptor-coactivator interface mediates negative feedback regulation of the human pituitary-thyroid axis

      ea0029oc2.4
    • Thyroid spongiform nodules are the best candidates for percutaneous laser ablation. A 5 year follow-up study in 72 patients

      ea0029oc2.5
    • Concurrent presence of nonendocrine autoimmune diseases with Hashimoto's thyroiditis: a systematic assessment on more than 5000 consecutive patients

      ea0029oc2.6
  • Diabetes Clinical
  • • Common variants of monogenic diabetes genes may affect [beta] cell functional mass in patients with newly diagnosed type 2 diabetes

      ea0029oc3.1
    • Weight-loss independent metabolic benefits of gastric bypass surgery? Experiences from the Swedish obese subjects (SOS) study

      ea0029oc3.2
    • Diabetic ketoacidosis at diagnosis influences complete remission after treatment of hematopoietic stem cell transplantation in adolescents with type 1 diabetes

      ea0029oc3.3
    • Glucose lowering therapies and cancer specific mortality in adult insulin-treated diabetes

      ea0029oc3.4
    • Study of toll like receptor 2 and 4 expression in monocytes in type 1 diabetes mellitus with and without micro-vascular complications

      ea0029oc3.5
    • Glucose disorders exert a detrimental effect on total brain volume in the elderly: a 2-year prospective MRI study

      ea0029oc3.6
  • Pituitary Basic
  • • Obestatin plays an opposite role in the regulation of pituitary somatotrope and corticotrope function in primates and mice

      ea0029oc4.1
    • Transcriptional regulation of prolactin by oestrogen in vivo

      ea0029oc4.2
    • miR-26a targets PRKCD in ACTH pituitary adenoma

      ea0029oc4.3
    • Identification of coupling specificity between somatostatin receptor 5 (SST5) and G proteins by a bioluminescence resonance energy transfer (BRET) technique: the role of GoA protein

      ea0029oc4.4
    • Targeting the IGF-IR system in pituitary tumors in vitro: antiproliferative action [amp] pitfalls

      ea0029oc4.5
    • Cell cycle G2/M transition is modulated by microRNAs in pituitary adenomas

      ea0029oc4.6
  • Obesity Basic
  • • GH ameliorates impaired glucose tolerance in obese mice by modifying the visceral fat condition through adiponectin

      ea0029oc5.1
    • Production of galectin-1, -3, -9 and -12 in adipose tissue of lean and obese mice

      ea0029oc5.2
    • Insulin action in brown adipose tissue is compromised during diet-induced obesity

      ea0029oc5.3
    • Bile acid binding resin shows anti-obese effect through the modifications of intestinal microbiota

      ea0029oc5.4
    • Development of leptin deficient Lepmkyo/Lepmkyo rat-evidence for its superiority over Lepob/Lepob mouse as a model for human obesity

      ea0029oc5.5
    • Semaphorin 3C-a novel adipokine modulating human adipose tissue plasticity in weight change

      ea0029oc5.6
  • Female Reproductioin Basic
  • • GnRH release failure in hyperprolactinemia is caused by a Kisspeptin deficiency

      ea0029oc6.1
    • Ghrelin modulates fertilization, early embryo development and implantation

      ea0029oc6.2
    • LH and hCG produce different responses in human granulosa lutein cells in vitro

      ea0029oc6.3
    • Female fertility and activin-stimulated Fshb expression do not require SMAD2/3 in murine gonadotropes

      ea0029oc6.4
    • Dihydrotestosterone treatment in mice induces a persistent polycystic ovary syndrome phenotype

      ea0029oc6.5
    • Kit ligand-c-kit interaction regulates estradiol production by rat granulosa cells via oocyte factors

      ea0029oc6.6
  • Adrenal Clinical
  • • Progression-free survival without treatment of malignant pheochromocytoma and paraganglioma at one year

      ea0029oc7.1
    • Activation of the PKA pathway triggers formation of an illicit serotonergic regulatory loop in primary pigmented nodular adrenal disease (PPNAD) tissues associated with Cushing's syndrome

      ea0029oc7.2
    • Ribonucleotide reductase large subunit (RRM1) gene expression predicts efficacy of adjuvant mitotane in adrenocortical cancer

      ea0029oc7.3
    • Differential diagnosis of primary aldosteronism by peripheral plasma levels of 18-oxo-cortisol: a noninvasive method with a high specificity

      ea0029oc7.4
    • Continuous subcutaneous hydrocortisone infusion (CSHI) as replacement therapy in Addison's disease (AD)

      ea0029oc7.5
    • Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study

      ea0029oc7.6
  • Bone
  • • Hypophosphatasia: enzyme replacement therapy (ENB-0040) decreases TNSALP substrate accumulation and improves functional outcome in affected adolescents and adults

      ea0029oc8.1
    • Comparison of high protein and normal protein weight loss diets on bone density in overweight post-menopausal women

      ea0029oc8.2
    • Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts

      ea0029oc8.3
    • Radiological vertebral fractures in hospitalized elderly patients with heart failure

      ea0029oc8.4
    • Pathogenetic chromosomal rearrangements in a large series of patients with pseudohypoparathyroidism type I

      ea0029oc8.5
    • Simultaneous gain and loss of methylation at imprinted loci in a subset of patients with pseudohypoparathyroidism type 1b and GNAS epimutations

      ea0029oc8.6
  • Endocrine Tumours & Translation
  • • Temozolomide therapy for progressive metastatic paraganglioma/pheochromocytoma: SDHB mutation as a prognosis biomarker for efficacy

      ea0029oc9.1
    • GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells

      ea0029oc9.2
    • The central role of estrogen receptor [alpha] in IGF2 dependent adrenocortical carcinoma (ACC) cell proliferation suggests the use of selective estrogen receptor modulators (SERMs) for the treatment of ACC

      ea0029oc9.3
    • Functional characterization of mutations in the multiple endocrine neoplasia type 1 (MEN1) gene suggest therapeutic strategies

      ea0029oc9.4
    • Glucagon-like peptide 1 receptor (GLP-1R) imaging for the preoperative localization of benign insulinomas in 30 patients

      ea0029oc9.5
    • First in vitro study of human gastroenteropancreatic-neuroendocrine tumors: comparative effect of octreotide and pasireotide

      ea0029oc9.6
  • Pituitary Clinical 2
  • • Predictors of morbidity and mortality in acromegaly: an Italian survey on behalf of the Italian study group of acromegaly

      ea0029oc10.1
    • Food intake regulating hormones in adult craniopharyngioma patients

      ea0029oc10.2
    • Pathophysiology of renal calcium handling in acromegaly revisited

      ea0029oc10.3
    • Higher glucocorticoid supplementation doses are associated with increased overall mortality in patients with non-functioning pituitary adenoma

      ea0029oc10.4
    • Once-weekly, CTP-modified hGH (MOD-4023) is effective in growth hormone deficient adults: a phase II, dose and frequency finding study

      ea0029oc10.5
    • Second neoplasms in childhood cancer survivors with growth hormone deficiency treated or not treated with GH

      ea0029oc10.6
  • Thyroid Clinical 2
  • • Growth retardation and severe constipation due to the first human, dominant negative thyroid hormone receptor alpha mutation

      ea0029oc11.1
    • Subclinical thyroid disease and risk of new-onset atrial fibrillation

      ea0029oc11.2
    • Is overt hypothyroidism associated with increased mortality? A nationwide register-based study of disease discordant Danish twins

      ea0029oc11.3
    • Prevalence of TSH receptor mutation and clinical characteristics among 84 patients with hyperthyroidism with diffuse goiter and negative TBII

      ea0029oc11.4
    • Thyroid hormones and male sexual function

      ea0029oc11.5
    • Is age a risk factor for hypothyroidism in pregnancy? An analysis of 5223 pregnant women

      ea0029oc11.6
  • Obesity Clinical
  • • Circulating endocannabinoids are associated to cardiometabolic alterations independently from adiposity

      ea0029oc12.1
    • Lipid-induced insulin resistance is associated with a reduction of IGF1 bioactivity independent of changes in IGFBP-1 and -2 in humans

      ea0029oc12.2
    • Transient increase of beta-cell first phase secretion after smoking cessation: a possible contributor to carbohydrate craving and body weight gain?

      ea0029oc12.3
    • Genetic susceptibility, birth weight and obesity risk in young chinese

      ea0029oc12.4
    • Brown adipose tissue activation is inversely related with central obesity and metabolic parameters in adult human

      ea0029oc12.5
    • Eating speed and the risk of type 2 diabetes mellitus: a case-control study

      ea0029oc12.6
  • Adrenal Basic
  • • Targeting multiple signalling pathways showed high anti-tumour potential in two mouse phaeochromocytoma cell lines

      ea0029oc13.1
    • VSNL1 is upregulated in aldosterone producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis

      ea0029oc13.2
    • Cortisol secretion is dependent on intraadrenal production of ACTH in macronodular bilateral adrenal hyperplasia causing Cushing's syndrome

      ea0029oc13.3
    • A genome-wide methylation study of adrenocortical tumors shows specific alterations linked to gene expression, revealing new aspects of the molecular classification of adrenal carcinomas

      ea0029oc13.4
    • KCNJ5 mutations in Japanese patients with aldosterone-producing adenomas

      ea0029oc13.5
    • GATA-4 overexpression induces adrenocortical tumorigenesis and ectopic expression of luteinizing hormone receptor in C57Bl/6J mice

      ea0029oc13.6
  • Male Reproduction
  • • X chromosome-linked copy number variations in male infertility

      ea0029oc14.1
    • Deficient expression of genes involved in the endogenous defense system against transposons in cryptorchid boys with impaired mini-puberty

      ea0029oc14.2
    • Comparison of serum testosterone and estradiol levels in 3174 European men as measured by a platform immunoassay and mass spectrometry; relevance for the diagnostics in aging men

      ea0029oc14.3
    • The prevalence of hypogonadism in men on methadone maintenance

      ea0029oc14.4
    • The muenster EXAKT project: X-inactivation in klinefelter patients

      ea0029oc14.5
    • Erectile dysfunction after liver transplantation

      ea0029oc14.6
  • Thyroid Basic
  • • PATZ1 is a new candidate tumour-suppressor gene in thyroid cancer

      ea0029oc15.1
    • Ligand bound-thyroid hormone receptor contributes to reprogramming of pancreatic exocrine cells to insulin-producing cells via induction of Ngn3 and MafA

      ea0029oc15.2
    • Radioiodine therapy of non-thyroidal cancer following systemic sodium iodide symporter (NIS) gene transfer using Transferrin-receptor (Tfr) targeted non-viral gene delivery vectors

      ea0029oc15.3
    • The DNA methylation as a predisposition factor in the pathogenesis of congenital hypothyroidism in premature infants

      ea0029oc15.4
    • Lymphatic endothelial markers podoplanin and Prox1 in differentiated thyroid tumors

      ea0029oc15.5
    • Thyroglobulin induces thyroid cell growth through suppression of miR-16 and miR-195

      ea0029oc15.6
  • Female Reproduction Clinical
  • • The association between birth weight and PCOS in adult life. A register-based study on 523, 757 Danish women born 1973-1991

      ea0029oc16.1
    • The first missense mutation of BMP15 mature domain identified in a Chinese family with primary ovarian insufficiency causes defective production of the bioactive protein

      ea0029oc16.2
    • Anti-mullerian hormone as a predictor of ovarian response to weight loss in overweight women with polycystic ovary syndrome

      ea0029oc16.3
    • Epidemiological survey on the prevalence of hyperandrogenic states in adolescent and young women

      ea0029oc16.4
    • Urinary glucocorticoid metabolite excretion is associated with insulin resistance independent of body mass index (BMI) in patients with polycystic ovary syndrome

      ea0029oc16.5
    • Kisspeptin-10 stimulation of gonadotropin secretion in women is modulated by sex steroid feedback

      ea0029oc16.6
  • Diabetes Basic
  • • Pdk1/Foxo1 pathway regulates macrophage migration, polarization, and insulin sensitivity

      ea0029oc17.1
    • Placental restriction co-ordinately alters hepatic expression of microRNAs and targets related to non alcoholic fatty liver disease, in adult male sheep

      ea0029oc17.2
    • Caerulin precursor fragment (CPF-AM1): a novel insulinotropic peptide from the skin secretion of the clawed frog, Xenopus amieti

      ea0029oc17.3
    • Syntaxin-3 regulates recruitment and exocytosis of newcomer insulin granules and granule-granule fusion during biphasic glucose-stimulated insulin secretion in pancreatic [beta]-cells

      ea0029oc17.4
    • Glucocorticoid receptor [alpha] expression is downregulated in gluteal subcutaneous adipose tissue of black South African women and associates with increased metabolic risk

      ea0029oc17.5
    • Meta-analysis of differentially expressed microRNAs in type 1, type 2 and gestational diabetes mellitus

      ea0029oc17.6
  • Paediatric Endocrinology
  • • Mutations in the NR5A1 gene in patients with 46,XY disorders of sex development (DSD): high frequency of familial multi-generational occurrence

      ea0029oc18.1
    • Clinical profile, gender choice and long term follow up of subjects with 5 alpha-steroid reductase 2 deficiency

      ea0029oc18.2
    • Effects of vitamin D insufficiency and its correction on insulin sensitivity and serum osteocalcin concentration in obese children

      ea0029oc18.3
    • Mortality in GH-treated (Tx) patients (pts) enrolled in the global genetics and neuroendocrinology of short stature international study (GeNeSIS)

      ea0029oc18.4
    • Earlier reactivation of the hypothalamo-pituitary-gonadal axis and advancement of puberty in boys under labour stress

      ea0029oc18.5
    • Functional characterization of a new mutation in the NKX2.1 in patients with thyroid-lung-brain syndrome

      ea0029oc18.6
  • Cardiovascular Endocrinology
  • • Both EPA/AA ratio and absolute AA levels constitute an independent risk factor for coronary atherosclerosis in type 2 diabetic patients

      ea0029oc19.1
    • Increased arterial stiffness is independently associated with cerebral infarctions and white matter lesions in patients with type 2 diabetes despite good blood pressure and lipid control

      ea0029oc19.2
    • Copeptin and adrenomedullin in a large cohort of patients with coronary heart disease and newly diagnosed glucose intolerance ('Silent diabetes study')

      ea0029oc19.3
    • Oxytocin is cardioprotective hormone

      ea0029oc19.4
    • Circulating adrenomedulin levels are associated with atrial natriuretic peptide and brain natriuretic peptide levels in heart failure patients

      ea0029oc19.5
    • Endothelial progenitor cells in acromegaly are reduced and responsive to treatment with somatostatin analogues

      ea0029oc19.6
• Nurses Abstracts
• • (1)
  • • Clinical practice guideline on linear growth measurement of children

      ea0029n1
    • The nurse's role in establishing modern testosterone replacement therapy in an endocrine clinic

      ea0029n2
    • Interdisciplinary risk assessment and patient discharge management: combining biomarker [amp] clinical scores, medical [amp] nursing aspects

      ea0029n3
    • Effect of metformin in teenagers with metabolic syndrome

      ea0029n4
    • Translation and cultural adaptation of the Brazilian version of patient assessment of chronic illness care: Pacic-Brazil

      ea0029n5
    • Perception of quality of care in patients with pituitary disorders

      ea0029n6
    • Neutralization of Flightless I (Flii) using Flii-specific monoclonal antibodies accelerates impaired healing in diabetic wounds through improved cell proliferation

      ea0029n7
    • Diabetes nurse leadership group: a forum for improving diabetes care in Brooklyn, NY

      ea0029n8
    • Childhood osteoporosis: screening, prevention, treatment and safe handling practices in a tertiary care pediatric hospital

      ea0029n9
    • Endocrine and exocrine function changes in acute pancreatitis

      ea0029n10
    • A prospective study of growth and development of children recently adopted from orphanage care

      ea0029n11
    • Improving the efficiency and safety of managing children with diabetic keto-acidosis

      ea0029n12
    • Socio-demographic factors associated with pediatric diabetic ketoacidosis admissions in Southern West Virginia

      ea0029n13
    • Failure to thrive due to inherited congenital isolated growth hormone deficiency

      ea0029n14
    • Diabetic foot in jordan: a qualitative content analysis of self-treated problems

      ea0029n15
    • Planning for the future: preparing the endocrine specialist nurse of tomorrow

      ea0029n16
    • The Swedish pituitary registry

      ea0029n17
    • Molecular genetics in turner syndrome

      ea0029n18
    • An Internet based protocol for examining transitional experiences of 16-26 year olds with Turner syndrome (TS)

      ea0029n19
    • Self care practice among diabetic patients attending metropolyclinic, Kathmandu

      ea0029n20
    • Abstract unavailable

      ea0029n21
    • Eat, Pray, Love...Yourself

      ea0029n22
    • Dance for health: implementation of a dance program to improve physical activity of children

      ea0029n23
    • Self-care competence in the case of Brazilian patients with diabetes mellitus in a multiprofessional educational programme

      ea0029n24
    • Primary hyperparathyroidism, vitamin D deficiency and quality of life

      ea0029n25
    • Evaluation of self management and diabetes education newly diagnosed with Type 2 diabetic patients in Mongolia

      ea0029n26
    • Individuals with Addison's disease and their experiences of onset and self-care: new knowledge?

      ea0029n27
    • A survey of knowledge related to cystic fibrosis related diabetes

      ea0029n28
• Poster Presentations
• • Adrenal cortex
  • • Targeting mutated [beta]-catenin in vitro and in vivo inhibits cell proliferation and stimulates apoptosis: a promising therapeutic target in adrenocortical carcinoma

      ea0029p1
    • Pathophysiological significance of CYP11B2 immunohistochemical staining in primary aldosteronism

      ea0029p2
    • The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in the diagnosis of subclinical hypercortisolism (SH) in patients with adrenal incidentaloma (AI).

      ea0029p3
    • Semen parameters in men with congenital adrenal hyperplasia (CAH) due to 21-hydroxilase deficiency (21-HD)

      ea0029p4
    • Non-radioactive strategies on the diagnosis of congenital adrenal hyperplasia due to 21 hydroxylase deficiency (CAH - 21OHD).

      ea0029p5
    • Diagnostic value of urinary steroid profiling in the evaluation of adrenal incidentaloma.

      ea0029p6
    • The combined use of nocturnal salivary cortisol and urinary cortisol to creatinine ratio in the evaluation of cycling in patients with Cushing's syndrome

      ea0029p7
    • Defining 17[alpha]-hydroxylase in zebrafish: expression pattern of two paralog genes (zCyp17a1; zCyp17a2) and comparative in vitro and in silico analysis

      ea0029p8
    • Progressive adrenal insufficiency in a patient with 46,XY DSD caused by two novel mutations in the cytochrome P450 side-chain cleavage (CYP11A1) gene

      ea0029p9
    • The mTOR-pathway in normal and tumoral human adrenocortical tissues

      ea0029p10
    • Measurement of cortisol in scalp hair can be a new tool in the diagnosis and follow-up of patients with Addison's Disease and (cyclic) Cushing's Syndrome

      ea0029p11
    • Pattern of adrenal hormonal secretion in patients with adrenal adenomas: the relevance of aldosterone in arterial hypertension

      ea0029p12
    • Influence of unilateral adrenalectomy on set point of Hypothalamic-pituitary-adrenal-axis in long-term survivors of childhood nephroblastoma and neuroblastoma

      ea0029p13
    • PET-tracers for differential diagnosis in primary hyperaldosteronism - in vitro studies

      ea0029p14
    • Role of Endogenous Somatostatin and Cortistatin in Regulating Adrenal Gland Function

      ea0029p15
    • Cyclical Cushing's syndrome masquerading as Polycystic Ovarian Syndrome - pitfalls in diagnosis

      ea0029p16
    • Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy

      ea0029p17
    • Use of the 250 mcg short synacthen test in the diagnosis of primary aldosteronism

      ea0029p18
    • Evaluation of sexual function and psychological attitudes in adult women with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase Deficiency (21-HD)

      ea0029p19
    • Role of adrenal vein sampling in primary aldosteronism. Impact of different diagnostic criteria on subtype diagnosis

      ea0029p20
    • Predicting factors of the post-surgical decline in renal function in patients with primary aldosteronism

      ea0029p21
    • Specialized surgery for adrenocortical carcinoma in The Netherlands: analysis of national cancer registry data

      ea0029p22
    • Long term follow-up of patients with adrenal incidentalomas - a prospective study

      ea0029p23
    • Effects of sugar cane extract (SCE) supplementation on steroidogenesis of the adrenal cortex in male rats

      ea0029p24
    • Evaluation of renal function of primary aldosteronism between pre- and post-treatment

      ea0029p25
    • Follow-up of nonsurgical nonfunctioning adrenal adenomas at five years

      ea0029p26
    • Importance of the genetic study in fertile women with nonclassical congenital adrenal hyperplasia

      ea0029p27
    • Aldosterone-producing cells regenerated from mesenchymal stem cells

      ea0029p28
    • The ACTH-independent macronodular adrenal hyperplasia gene hunt: from candidate genes to a pangenomic strategy

      ea0029p29
    • Superselective adrenal venous sampling for intra-adrenal localization of aldosterone hypersecretion.

      ea0029p30
    • Analysis of the glucocorticoid receptors polymorphism in patients with adrenal incidentaloma and patients with Cushing's syndrome.

      ea0029p31
    • KCNJ5 Mutations in European Families with Non-Glucocorticoid Remediable Familial Hyperaldosteronism

      ea0029p32
    • Applicability of the guideline for the diagnosis of primary hyperaldosteronism in patients with hypertension in Japan (PHAS-J2): Prospective multi-center study of national hospital organization

      ea0029p33
    • Copy number alterations and loss of heterozygosity in cortisol-secreting adrenocortical adenomas using SNP arrays: evidence of new candidate genes and pathways.

      ea0029p34
    • Differential DNA methylation of the CYP11B1 and CYP11B2 genes in association with human adrenal zonation

      ea0029p35
    • Super-selective ACTH-stimulated adrenal venous sampling can discriminate the main lesion from the normal tissue for doing partial adrenalectomy in unilateral aldosterone-producing adenoma

      ea0029p36
    • Deletion of TASK3 K+ channels leads to hyperaldosteronism in neonatal mice

      ea0029p37
    • Expression of kisspeptin and its receptor in aldosterone-producing adrenal adenomas

      ea0029p38
    • Reduction of the 10-year probability of fracture predicted by FRAX[reg] and bone mass recovery in patients with Cushing's Syndrome after 24 months from cure of hypercortisolism

      ea0029p39
    • The Wnt/Beta-catenin and Ras/Raf/MEK/ERK signaling pathways alterations in adrenocortical tumors

      ea0029p40
    • Cancer induces adrenal and pituitary alterations during the development of cachexia-anorexia syndrome

      ea0029p41
    • A revolution in the diagnosis of adrenal disorders: rapid multiplex quantitation of serum steroids by means of tandem mass spectrometry (MSMS)

      ea0029p42
    • Outcome of 232 patients with monolateral adrenal incidentaloma from a single centre

      ea0029p43
    • Female patients with primary aldosteronism are diagnosed earlier and have a better outcome

      ea0029p44
    • Influencing factors on quality of life in patients with Addison's disease

      ea0029p45
    • Differential methylation signature in benign and malignant cortisol producing adrenocortical tumors

      ea0029p46
    • 18-Hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes.

      ea0029p47
    • MicroRNA profiling of benign and malignant adrenocortical tumors reveals potential biomarkers of recurrence

      ea0029p48
    • Prevalence and Characteristics of Familial Hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino - GENetic forms).

      ea0029p49
    • Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modelling

      ea0029p50
    • Cornell product left ventricular hypertrophy in electrocardiogram in patients with primary aldosteronism

      ea0029p51
    • Efficacy of long-term treatment with retinoic acid in patients with Cushing's disease

      ea0029p52
    • Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort

      ea0029p53
    • Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency

      ea0029p54
    • Urinary cortisol metabolites in corticotroph and adrenal tumours

      ea0029p55
    • Soundwave's effect on hematic cortisol level: a pilot study

      ea0029p56
    • Reevaluation of the 4 mg intravenous dexamethasone suppression test for differentiation of Cushing's disease from pseudo-Cushing's syndrome

      ea0029p57
    • Treatment with mineralocorticoid receptor antagonists in 'subclinical' cases with adrenal adenomas and autonomous aldosterone secretion

      ea0029p58
    • The effects of the acute administration of alprazolam, a benzodiazepine, in patients with subclinical Cushing's syndrome

      ea0029p59
    • Is isolated secondary adrenal insufficiency more frequent than autoimmune Addison's disease?

      ea0029p60
    • Dyslipidemia in patients with adrenal incidentaloma with and without subclinical hypercortisolism and diabetes mellitus.

      ea0029p61
    • Prevalence of primary aldosteronism in Chinese patients with resistant hypertension

      ea0029p62
    • Genetic, anthropometric and metabolic features of adult norwegian patients with 21-hydroxylase deficiency

      ea0029p63
    • Relationship between plasma dexamethasone level and cortisol in the overnight dexamethasone suppression test

      ea0029p64
    • Mechanisms of gastroprotective action of corticotropin-releasing factor (CRF): involvement of CRF receptor subtypes 1 and 2

      ea0029p65
    • Comparison of salivary cortysol by chemiluminensce and mass spectometry in hypercortilosism

      ea0029p66
    • Renin-angiotensin-aldosterone system and inflammation - new aspects of an old system: results from the study of health in pomerania

      ea0029p67
    • MGMT expression in human adrenocortical carcinoma cell lines and tissues and effects of temozolomide on tumor cell growth.

      ea0029p68
    • New quick cortisol assay during adrenal vein sampling in patients with primary aldosteronism

      ea0029p69
    • Primary aldosteronism is very frequent in resistant hypertension and is associated to early renal vascular damage

      ea0029p70
    • Enhanced small dense LDL-subfractions, triglycerides and chemerin as early metabolic alterations in young patients with classic CAH due to 21-hydroxylase deficiency

      ea0029p71
    • ACTH and cortisol responses to the combined DEXA-CRH test in patients with adrenal incidentalomas

      ea0029p72
    • Idiopathic primary hyperaldosteronism frequently undergoes spontaneous remission: frequence and predictors

      ea0029p73
    • Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study

      ea0029p74
    • Drug prescription pattern in patients with autoimmune addison's disease in Sweden

      ea0029p75
    • Dosing regimens for glucocorticoid replacement therapy - a worldwide patient survey

      ea0029p76
    • Significance of ACTH stimulation test in the diagnosis of an aldosterone-producing adenoma

      ea0029p77
    • An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency

      ea0029p78
    • Malignant adrenal incidentalomas: clinical analysis of 2300 patients with adrenal incidentalomas registered at a single endocrinological center

      ea0029p79
    • RRM1 Gene expression affects metabolization and activity of mitotane in adrenocortical cancer cell lines.

      ea0029p80
    • The routine application of the current clinical recommendations for adrenal incidentalomas the management is highly inefficient

      ea0029p81
    • The Effect of Glucocorticoid Receptor Polymorphisms on the Sensitivity to Cortisol in Addison's disease

      ea0029p82
    • Impact of reference values and published thresholds on clinically relevant cut-offs

      ea0029p83
    • Hormonal and metabolic features in patients with adrenal incidentalomas according to 1 mg overnight dexamethasone suppression test

      ea0029p84
    • Therapy with steroidogenesis inhibitors in Cushing's syndrome: a reappraisal

      ea0029p85
    • Ectopic Cushings and Nocardia series

      ea0029p86
    • Laparoscopic adrenalectomy for large adrenal tumors

      ea0029p87
    • Adiponectin gene polymorphisms in primary aldosteronism and their relation to the metabolic syndrome

      ea0029p88
    • Primary aldosteronism associated with subclinical Cushing syndrome

      ea0029p89
    • Primary aldosteronism during 2007-2011 in Iceland

      ea0029p90
    • Low SLC26A2 expression in adrenal cells is associated with high aldosterone output

      ea0029p91
    • Three-dimensional contrast-enhanced sonography in the diagnosis of incidentally discovered asymptomatic adrenal masses

      ea0029p92
    • Evaluation of uni- and bilateral adrenal incidentalomas with (131I) 6[beta]-iodomethyl-norcholesterol scintigraphy.

      ea0029p93
    • The confirmatory Tests of primary aldosteronism should be selected in each countries - the analysis of 83 patients in our hospital

      ea0029p94
    • ACTH stimulation improves the sensitivity of aldosterone to rennin ratio (ARR) for detecting inappropriate aldosterone secretion

      ea0029p95
    • Diagnostics of primary aldosteronism: is obligatory use of confirmatory tests justified?

      ea0029p96
    • Diagnosis of Cushing's syndrome by automatic face classification using frontal and side-view photographs

      ea0029p97
    • Cushing disease remission is independent of size tumor. twenty years experience in surgical treatment a Mexican Center

      ea0029p98
    • Cushing's disease - limitations and boundaries

      ea0029p99
    • Exogenous corticosteroids: guilty or innocent?

      ea0029p100
    • Pediatric Cushing disease: case report

      ea0029p101
    • Proteomic approach to human adrenocortical cancer biology

      ea0029p102
    • GH deficiency in patients with hypoadrenalism

      ea0029p103
    • The functional assessment and growth rates of adrenal incidentalomas: a single center experience

      ea0029p104
    • Adrenal venous sampling: local experience in Asian population

      ea0029p105
    • Comparison of four immunoassays for measurement of cortisol levels

      ea0029p106
    • Tertiary adrenal insufficiency: case report

      ea0029p107
    • A case of HIV presenting as primary adrenal lymphoma

      ea0029p108
    • Ketoconazole in surgery preparation and follow-up of Cushing's disease - our experience

      ea0029p109
    • Utility of CGM for the determination of optimal glucocorticoid replacement method in patients with adrenal insufficiency

      ea0029p110
    • A case of subclinical Cushing's syndrome who developed pseudo-aldosteronism caused by green juice

      ea0029p111
    • Adrenal masses as the first demonstration of non endocrine tumors metastatic disease

      ea0029p112
    • Usefulness of FDG-PET for detecting primary aldosteronism in patient who have bilateral adrenal incidentaloma

      ea0029p113
  • Adrenal medulla
  • • Next generation sequencing is a cost effective and time saving method in clinical genetic screening of patients with pheochromocytomas

      ea0029p114
    • Pheochromocytomas: a single centre experience

      ea0029p115
    • Removal of the dominantly secreting adrenal lateralized by bilateral adrenal venous sampling (BAVS) with glucagon stimulation significantly alleviated hypertension in patients with bilateral adrenal pheochromocytoma

      ea0029p116
    • Neuroendocrine markers in biochemical vs pathology diagnosis of pheochromocytoma

      ea0029p117
    • Geranylgeraniols are essential for adrenal catecholamine secretion

      ea0029p118
    • Neither classical symptoms of phaeochromocytoma nor elevated urinary catecholamines are always seen in patients with histologically verified phaeochromocytoma

      ea0029p119
    • The unique case of adrenal malignant non-functioning oncocytic pheochromocytoma

      ea0029p120
    • A rare case of adrenocorticotropic hormone-producing Pheochromocytoma

      ea0029p121
    • A Novel SDHC mutation associated with Head-Neck Paraganglioma

      ea0029p122
    • Features at presentation of adrenal pheochromocytomas in castilla la mancha (spain). Is the clinical spectrum changing ?

      ea0029p123
    • Incidentally discovered pheochromocytoma (PH)

      ea0029p124
    • Pheochromocytoma incidentally discovered after thyroid surgery manifesting dramatic hypertensive crisis induced by metoclopramide

      ea0029p125
    • A case of adrenoleukodystrophy presenting as progressive cerebellar dysfunction

      ea0029p126
    • Clinical peculiarities of pheochromocytoma in a MEN2A family

      ea0029p127
    • Pheochromocytoma in neurofibromatosis type 1

      ea0029p128
  • Bone & Osteoporosis
  • • Unilateral and bilateral adrenal incidentaloma: comparing clinical and biochemical features

      ea0029p129
    • Bone mineral density is associated with BsmI vitamin D receptor's polymorphism in adult patients with epilepsy

      ea0029p130
    • Vitamin D and estrogen receptors' polymorphisms in postmenopausal women

      ea0029p131
    • Osteoporosis and vitamin D deficiency in patients with lipid storage disease

      ea0029p132
    • De novo autoimmune hepatitis associated with PTH(1-34) and PTH(1-84) administration for severe osteoporosis in a liver transplant patient

      ea0029p133
    • Osteogenesis imperfecta: phenotypic characteristics and response to treatment in an Irish cohort

      ea0029p134
    • Bone mineral density in diabetic postmenopausal women with bone fracture

      ea0029p135
    • Evidence for vitamin D deficiency and increased fractures' prevalence in autoimmune bullous skin diseases

      ea0029p136
    • A correlation between bone mass density and body mass index and the lipid profile?

      ea0029p137
    • Vertebral fracture risk and bone metabolism in patients with addison's disease

      ea0029p138
    • Bone mineral density and muscle mass in women with multiple sclerosis

      ea0029p139
    • Teriparatide: effects on cortical bone microstructure

      ea0029p140
    • Serum soluble RANKL levels are related to breast arterial calcification and hypertension in Japanese osteoporotic postmenopausal women

      ea0029p141
    • BMP-3b inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling

      ea0029p142
    • Glucocorticoid - treatment in the adrogenital syndrome due to deficit of 21-hydroxylase: long-term bone side effects

      ea0029p143
    • Polymorphism of the vitamin D3 receptor gene and bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment

      ea0029p144
    • Altered bone mineral density in unilaterally orchiectomized subjects

      ea0029p145
    • Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria and recurring renal calcium lithiasis

      ea0029p146
    • Bone mineral density in patients with thalassaemia major in the UK

      ea0029p147
    • Abstract unavailable

      ea0029p148
    • Both high- and low levels of procollagen type 1 amino-terminal propeptide are associated with increased risk of hip fracture in elderly women. Norwegian Epidemiologic Osteoporosis Studies

      ea0029p149
    • Alendronate inhibits adipocyte differentiation in 3T3-L1 through a Vitamin D receptor mediated effect

      ea0029p150
    • Genetic predispositions do not explain short- and long-term effects of hormonal therapy on bone mineral density in girls with functional hypothalamic amenorrhea

      ea0029p151
    • Improved assessment of bone turnover by the PTH-(1-84)/ large C-PTH fragments ratio in dialysis patients

      ea0029p152
    • Comparaison of serum PTH concentrations obtained with a second and a third generation assay in a cohort of hemodialysis patients according to the KDIGO guidelines

      ea0029p153
    • Endoscopic comparison of esophageal and gastroduodenal mucosal effects of enterocoating alendronate with calcitriol combined drug and alendronate in Korean postmenopausal women

      ea0029p154
    • Functional hypoparathyroidism is a risk factor for bone fragility of postmenopausal women with vitamin D insufficiency

      ea0029p155
    • Platinum nanoparticle reduces ovariectomy-induced bone loss by decreasing osteoclastogenesis

      ea0029p156
    • The level of Osterix expression in osteoblasts is important to prevent IL6-induced inflammatory-prone state

      ea0029p157
    • Osteopenia/osteoporosis in patients with calcium nephrolithiasis

      ea0029p158
    • No effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy

      ea0029p159
    • Bone cross-sectional geometry and strength parameters at the radius by pQCT in male obese adolescents

      ea0029p160
    • Osteonecrosis of the jaw (ONJ) with superimposed osteomyelitis related to actinomyces in a patient with multiple myeloma receiving thalidomide and intravenous zoledronic acid

      ea0029p161
    • Effect of alcohol consumption on bone mineral density in healthy elderly Spanish males

      ea0029p162
    • Effect of alendronate on bone mineral density in primary hyperparathyroidism

      ea0029p163
    • Association of monocyte chemoatractant protein-1 and adiponectin with bone mineral density and osteocalcin in postmenopausal women

      ea0029p164
    • Age-dependent and sexual features of bone mineral density changes in rats with hyperthyroidism

      ea0029p165
    • Sinomaxillary myopericytoma associated with oncogenic osteomalacia

      ea0029p166
    • Body composition in postmenopausal women with vertebral fractures

      ea0029p167
    • Bone mineral density in relation to metabolic syndrome in postmenopausal women with diabetes type 2

      ea0029p168
    • Assessment of bone turnover and vitamin D levels in women with postmenopausal osteoporosis and type 2 diabetes mellitus

      ea0029p169
    • Osteoblast and adipocyte differentiation from human adipose tissue-derived cells

      ea0029p170
    • Denosumab increases BMD in primary hyperparathyroidism

      ea0029p171
    • Relationship between bone metabolism markers, bone mineral density and insulinresistance in healthy and diabetic postmenopausal women

      ea0029p172
    • The relation between quantitative characteristics of smoking and level of female skeleton damage

      ea0029p173
    • The assessment of the behavior of the interleukins IL1[beta] and IL6 and bone mineral density (BMD) and bone metabolism (IBM) in women of postmenopausal age

      ea0029p174
    • Correction of bone mineral density losing in female rats with exogenous thyrotoxicosis with calcium and alendronate preparations

      ea0029p175
    • Reference intervals for serum N-MID osteocalcin concentration measured with the IDS-iSYS automated system

      ea0029p176
    • Prevalence of morphometric vertebral fractures and bone quality measured by spinal deformity index in type 1 diabetic patients

      ea0029p177
    • Clinical evaluation of a new specific 1-84 PTH automated platform

      ea0029p178
    • Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels

      ea0029p179
    • Investigating recurrent hypophostaemia

      ea0029p180
    • Ovariectomy modulates the effect of phytoestrogens on creatine kinase specific activity in skeletal organs in female rats

      ea0029p181
    • Bone turnover markers in medicamentous and physiological hyperprolactinemia in female rats

      ea0029p182
    • Adiponectin and bone mineral density in obese postmenopausal women

      ea0029p183
    • The body mass index and heel quantitative ultrasound analyze in 300 women

      ea0029p184
    • Cimetidine (histamine H2-receptor antagonist and antiandrogenic drug) exerts a beneficial effect in the injured tissues by periodontal disease in male rat molars

      ea0029p185
    • Age-dependent and sexual features of bone mineral density changes in rats in remote terms after hyperthyroidism abolition

      ea0029p186
    • Features of bone mineral density losing in ukranian woman of different ages with thyrotoxicosis

      ea0029p187
    • Comparison of the effects of hormone replacement therapy on bone mineral density, lipid profiles, and biochemical markers of bone metabolism

      ea0029p188
    • Bone mass in diabetic patients measured by lumbar spine and hip densitometry

      ea0029p189
    • Efficacy, safety and adherence to treatment of teriparatide: an observational study

      ea0029p190
    • Thyroxin treatment of multinodular and normofunctional goiter and bone mass.

      ea0029p191
    • Vitamin D status in patients treated with intravenous ibandronate: a cohort study

      ea0029p192
    • Correlations between the bone matrix markers and bone mineral density in postmenopausal osteoporosis

      ea0029p193
    • Zoledronic acid treatment improve bone strenght parameters assessed by BMD

      ea0029p194
    • Therapeutical management in hypogonadal osteoporosis

      ea0029p195
  • Calcium & Vitamin D metabolism
  • • PTH levels are associated with insulin resistance in PCOS women

      ea0029p196
    • Dietary effect of calcium and vitamin D on the gene expressions of tight junction in the duodenum and kidney of calbindin-D9k, -D28k and -D9k/D28k knockout mice

      ea0029p197
    • Serum IGF1 concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D

      ea0029p198
    • Incidence of diabetes and vitamin D deficiency: a prospective cohort study

      ea0029p199
    • Tissue-specific expression of transcellular calcium transport and paracellular tight junction genes in the placentas of calbindin-D9k, -D28k, and -D9k/D28k knockout mice

      ea0029p200
    • Gitelman's syndrome presenting with hypercalcaemia due to severe primary hyperparathyroidism

      ea0029p201
    • Vitamin D pathway in non-functioning pituitary adenomas

      ea0029p202
    • A new cause of malignancy associated hypercalcemia (MAH): PTH releasing breast cancer

      ea0029p203
    • Two cases of alendronate induced atypical fracture of femur shaft

      ea0029p204
    • Vitamin D levels and carbohydrate metabolism

      ea0029p205
    • A single metastatic lesion in the leg of a parathyroid carcinoma

      ea0029p206
    • Pseudohypoparathyroidism type Ia, hypothyroidism and insulin resistance

      ea0029p207
    • A diagnostic conundrum associated with hypercalcaemia

      ea0029p208
    • Expression of 25-hydroxyvitamin D3-1[alpha]-hydroxylase and 24-hydroxylase in human vascular smooth muscle cells

      ea0029p209
    • Longitudinal changes in serum 25-hydroxyvitamin D levels of older persons during 6 and 13 years of follow-up

      ea0029p210
    • Primary hyperparathyroidism, vitamin D deficiency and quality of life

      ea0029p211
    • Cinacalcet treatment in MEN1-associated hyperparathyroidism: a clinical trial

      ea0029p212
    • Serum levels of soluble secreted [alpha]-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis

      ea0029p213
    • Lack of effects of high dose colecalciferol (D3) on insulin sensitivity and metabolic markers in type 2 diabetic patients: a double-blind, randomised, placebo-controlled trial

      ea0029p214
    • Blood pressure after parathyroidectomy in patients with primary hyperparathyroidism and hypertension

      ea0029p215
    • Serum cystatin C is a reliable predictor of renal function and cardiometabolic risk in primary hyperparathyroidism

      ea0029p216
    • Usefulness of MS-MLPA for detection of genetic and epigenetic states of GNAS complex in Pseudohypoparathyroidism type1b

      ea0029p217
    • Pathophysiological changes in extracellular pH regulate calcium-sensing receptor responsiveness in HEK-293 and isolated parathyroid cells but not as a result of altered histidine residue ionisation

      ea0029p218
    • Normocalcemic hyperparathyroidism: a personal experience

      ea0029p219
    • Cardiac structure and functions in patients with asymptomatic primary hyperparathyroidism

      ea0029p220
    • Perioperative management difficulties in parathyroidectomy for primary vs secondary and tertiary hyperparathyroidism

      ea0029p221
    • Evaluation of glucose metabolism in primary hyperparathyroid patients

      ea0029p222
    • The prevalence of hypocalcaemia with low parathyroid hormone level in Polish elderly population

      ea0029p223
    • Obesity, carbohydrate, lipid metabolism and polymorphisms (Fok, Bsm) of vitamin D receptor gene in aging population: POLSENIOR study

      ea0029p224
    • Quality of life in premenopausal women with vitamin D deficiency and vitamin D insufficiency

      ea0029p225
    • Intraoperative parathormone monitoring allows successful minimally invasive parathyroidectomy in patients with non concordant preoperative imaging

      ea0029p226
    • Vitamin D status, chronic kidney disease and secondary hyperparathyroidism in Polish elderly population

      ea0029p227
    • Vitamin D status in primary hyperparathyroidism: a 'Southern European' observational study

      ea0029p228
    • Vitamin D and rheumatoid arthritis

      ea0029p229
    • The prevalence of primary hyperparathyroidism in Polish elderly population

      ea0029p230
    • Markers of bone turnover and polymorphism of vitamin D receptor gene in aging population: POLSENIOR study

      ea0029p231
    • Endothelial functions of the patients with hyperparathyroidism

      ea0029p232
    • The importance of citrate and the calcium/citrate ratio in patients with calcium renal lithiasis and severe lithogenesis

      ea0029p233
    • The diagnostic values of serum intact parathyroid hormone, calcium and phosphorus for the prediction of vitamin D deficiency

      ea0029p234
    • Vitamin D and gestational diabetes

      ea0029p235
    • Bone biomarkers, body composition and metabolic profile in patients with primary hyperparathyroidism

      ea0029p236
    • The daily calcium intake is associated with sarcopenia in older, non-obese koreans: the fourth korea national health an nutrition examination surveys (KNHANES IV) 2009

      ea0029p237
    • Role of chromogranin-A in the truncation of parathyroid hormone in cultured parathyroid cells from patients of the secondary hyperparathyroidism

      ea0029p238
    • Correlations between vitamin D supply and PTH-intact and PTH-bio-intact levels in dialysis patients

      ea0029p239
    • Relationship among time outside, sun exposure, clothing worn, adiposity and serum 25(OH)D in overweight and obese adults

      ea0029p240
    • Prospects of patients with oligosymptomatic primary hyperparathyroidism

      ea0029p241
    • Cross-reactivity of 25-hydroxyvitamin D2 in ADVIA centaur vitamin D assay

      ea0029p242
    • Primary hyperparathyroidism: association of imaging and pathology

      ea0029p243
    • Vitamin D modulates composition of extracellular matrix in cultured human vascular cells

      ea0029p244
    • Vitamin D level and ALT level in Chinese-American patients with chronic hepaitits B in the new york city downtown area

      ea0029p245
    • High levels of parathormone after parathyroidectomy in primary hyperparathyroidism patients does not always mean disease recurrence...

      ea0029p246
    • Sporadic pseudohypoparathyroidism with osteitis fibrosa cystica

      ea0029p247
    • Vitamin D supply in healthy blood donors: is there relationship with the use of oral contraceptives?

      ea0029p248
    • Chronic hypercalcemia, an unusual presentation in Q1011E heterozygous CaSR polymorphism

      ea0029p249
    • Quantification of serum 25-hydroxyvitamin D: a comparison among immunoassay, HPLC-UV, and HPLC-MS

      ea0029p250
    • Vitamin D deficiency and insufficiency and secondary hyperparathyroidism in Ukrainian population

      ea0029p251
    • Prevalence of hypovitaminosis D in adult patients with hypopituitarism

      ea0029p252
    • Treatment of vitamin D insufficiency with oral loading doses of cholecalciferol

      ea0029p253
    • A 10-year study of vitamin D in Moldova

      ea0029p254
    • 25-Hydroxi-vitamin-D levels in clinical conditions with low plasma albumin

      ea0029p255
    • The impact of different vitamin D preparations for the treatment of vitamin D deficiency in primary hyperparathyroidism (PTHP)

      ea0029p256
    • Identification of a novel mutation in the calcium sensing receptor gene in FHH

      ea0029p257
    • Vitamin D status in patients with musculoskeletal symptoms in Haryana, India

      ea0029p258
    • Evaluation of the platelet functions in hyperparathyroid patients

      ea0029p259
    • The relation between endocrine and radiological changes in adolescents with vitamin D deficiency

      ea0029p260
    • Remember calcium! Fahr's syndrome diagnosed after repeated generalized seizures: a case report

      ea0029p261
    • Assessment of vitamin D 3 status in general population

      ea0029p262
    • Unrecognized severe vitamin D deficiency

      ea0029p263
    • Evaluation of clinical and laboratory findings of our primary hyperparathyroid patients

      ea0029p264
    • Experience in the treatment of primary hyperparathyroidism with cinacalcet: Preliminary data

      ea0029p265
    • Primary hypoparathyroidism presenting as adult onset seizure: a report of two cases

      ea0029p266
    • Vitamin D status in primary hyperparathyroidism

      ea0029p267
    • Vitamin D deficiency repletion in patients with co-existing vitamin D deficiency and primary hyperparathyreoidism: pro for early postoperative or preoperative treatment: case reports

      ea0029p268
  • Cardiovascular Endocrinology and Lipid Metabolism
  • • Testosterone replacement therapy inhibits key enzymes of fatty acid synthesis in mouse liver

      ea0029p269
    • Effect of testosterone on hepatic liver X receptor and ApoE expression as a potential mechanism of atheroprotection in the testicular feminised mouse

      ea0029p270
    • The effect of potassium supplementation on the endothelium, the renin-angiotensin-aldosterone system (RAAS) and blood pressure in patients at moderate cardiovascular disease risk

      ea0029p271
    • (Pro)renin Receptor is essential for filtration barrier in glomerular podocyte

      ea0029p272
    • Testosterone replacement therapy: a safety audit of clinical practice including men with Type 2 diabetes and cardiovascular disease

      ea0029p273
    • Thyroid axis hormones and cortisol are associated with subjective fatigue in patients with coronary artery disease

      ea0029p274
    • Familiar hypercholesterolemia: effects of treatment with rosuvastin

      ea0029p275
    • Metabolic and glycaemic profile in patients with acute coronary syndrome

      ea0029p276
    • Impact of 6-month course of 1 mg finasteride tablets on levels of lipid profile in men with androgenic alopecia

      ea0029p277
    • Transient glucocorticoid excess does not cause persisting metabolic changes in mice

      ea0029p278
    • Gastrectomy for early gastric cancer is associated with decreased cardiovascular mortality in accordance with amelioration of metabolic abnormalities, visceral adiposity and atherosclerosis

      ea0029p279
    • The role of testosterone activation of liver X receptor in a human macrophage cell line and its implications for the treatment of type 2 diabetes and atherosclerosis

      ea0029p280
    • Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human coronary arterial wall and pericoronary adipose tissue in correlation with atherosclerosis

      ea0029p281
    • Six loci associated with high-density lipoprotein cholesterol or triglycerides in Chinese pregnant women

      ea0029p282
    • Development of primary hyperparathyroidism is closely associated with the onset of dyslipidemia and insulin resistance in a large family harboring a MEN1 gene mutation

      ea0029p283
    • Level of adiponectin and vaspin, and adiponectin/vaspin ratio is associated with insulin resistance and clinical expression of metabolic syndrome in type 2 diabetic patients

      ea0029p284
    • Insulin mediates the glucagon-induced decrease in atrial natriuretic peptide: a randomized controlled trial

      ea0029p285
    • The role of [beta]-arrestin proteins in CB1 cannabinoid receptor endocytosis

      ea0029p286
    • Abstract unavailable

      ea0029p287
    • Plasma aldosterone to plasma renin ratio on an automated analyzer using two novel chemiluminescence immunoassays

      ea0029p288
    • Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study

      ea0029p289
    • Testosterone and cardiovascular risk in patients with erectile dysfunction

      ea0029p290
    • Oxytocin stimulates cardiomyogenesis and cardioprotection via stem cells activation

      ea0029p291
    • Metabolism of angiotensin II and angiotensin III in HAC15 cells

      ea0029p292
    • Chemerin/CMKLR1 and adiponectin/T-cadherin expression in human aortic wall and periaortic adipose tissue in correlation with atherosclerosis

      ea0029p293
    • In primary aldosteronism, plasma aldosterone concentration is an independent risk factor for albuminuria, and the higher baseline urinary albumin excretion predicts the less glomerular filtration rate after treatment

      ea0029p294
    • Relationships between insulin resistance and cardiovascular risk factors in primary hyperparathyroidism

      ea0029p295
    • Allosteric effects between the protomers of AT1 angiotensin receptor homodimer: role of the conserved DRY motif

      ea0029p296
    • Effect of triiodothyronine and angiotensin-II on expression of (pro)renin receptor in the human erythroid cell line, YN-1

      ea0029p297
    • The combined use of serum interleukin 6 and C-reactive protein is better than either alone in predicting cardiovascular events in a Chinese population

      ea0029p298
    • Short-term detraining cannot reverse insulin sensitivity improvement and serum retinol binding protein 4 in spontaneously hypertensive rats previously submitted to aerobic exercise

      ea0029p299
    • Multiple cardiovascular risk factors in patients with myotonic dystrophy type 1 and 2

      ea0029p300
    • Role of peroxisome proliferator-activated receptor-[gamma] (PPAR[gamma]) in regulation of glucocorticoid metabolism in vascular smooth muscle cells

      ea0029p301
    • Recombinant erythropoietin treatment enhances mitochondrial function in human skeletal muscle

      ea0029p302
    • Association of IL4 receptor gene polymorphisms with high density lipoprotein cholesterol

      ea0029p303
    • Cardiovascular risk factors in a large cohort of children with GH deficiency

      ea0029p304
    • Lipid profile in children with persistent idiopathic subclinical hypothyroidism

      ea0029p305
    • Variants of endothelial nitric oxide synthase gene are associated with components of metabolic syndrome in an Arab population

      ea0029p306
    • MRTF-A, a rho-dependent co-activator of SRF, regulates phenotypic modulation of vascular smooth muscle cells and plays an important role in vascular remodeling

      ea0029p307
    • Association of PON-1 activity and other anti-oxidative enzymes with long-chain fatty acids profile in T2DM

      ea0029p308
    • Risk factors of metabolic syndrome in adolescent with classical congenital adrenal hyperplasia

      ea0029p309
    • Alterations of protein expression profiles in 3T3-L1 adipocytes by interleukin 4

      ea0029p310
    • Anti-Mullerian hormone may be a hormonal regulator of the cardiovascular system

      ea0029p311
    • Anti-oxidataive actions of urocortin on HL-1 cardiomyocytes

      ea0029p312
    • Adipokine expression profile in pericoronary and periaortic adipose tissue in correlation with coronary and aortic atherosclerosis

      ea0029p313
    • Fatty liver index and lipid accumulation product index as markers of liver steatosis in premenopausal women with nonalcoholic fatty liver disease

      ea0029p314
    • Effects of long-term treatment of hypogonadal men with testosterone undecanoate on blood pressure, fasting glucose, HbA1c and C-reactive protein

      ea0029p315
    • Dysregulation of tissue renin-angiotensin-aldosterone system in obese hypertensive rats

      ea0029p316
    • The relationship between 25(OH)D levels and markers of atherosclerosis and inflammation in type 2 diabetic patients

      ea0029p317
    • Plasma total homocysteine levels in transsexuals after cross-sex hormonal treatment

      ea0029p318
    • Body composition and association to NT-proBNP and myostatin levels in heart failure patients

      ea0029p319
    • Subclinical atherosclerosis and arterial stiffness are associated with levels of circulating androgens in healthy recently menopausal women

      ea0029p320
    • Metabolic syndrome, hormone levels and inflammation in patients with erectile dysfunction

      ea0029p321
    • Duration effect of statin therapy on bone metabolism in dyslipidemic patients

      ea0029p322
    • Coronary flow reserve is inversely related to urinary cortisol in Cushing's syndrome

      ea0029p323
    • Myeloperoxidase is not associated with applications of coronary artery disease and type 2 diabetic patients

      ea0029p324
    • Analysis of hyponatremia in a tertiary hospital during a 5 year period

      ea0029p325
    • Effect of melatonin supplementation on lipid peroxidation and on the enzymes of antioxidative system in patients with chronic coronary artery disease.

      ea0029p326
    • N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with non-ST-elevation myocardial infarction (NSTEMI) compared to patients with unstable angina (UA) in a lot of patients admitted for non-ST-elevation acute coronary syndrome (NSTE-ACS)

      ea0029p327
    • Effect of medical therapy on 24-h blood pressure profile in acromegaly

      ea0029p328
    • Polycystic ovary syndrome induces leukocyte/endothelial cell interactions

      ea0029p329
    • Effect of weight loss on C3 and C4 components of complement in obesity

      ea0029p330
    • Vitamin D serum levels and cardiovascular risk factors in postmenopausal women

      ea0029p331
    • Sympathetic over-activity and low adrenocortical responses to hypoglycemia in patients in early stage of hypertension

      ea0029p332
    • The effect of thyroxine replacement on reduction of small dense low-density lipoprotein (sdLDL) in patients with primary hypothyroidism.

      ea0029p333
    • Metabolic consequences of obesity in children and adolescents

      ea0029p334
    • Study on the DHEA-S secretion dynamics in elderly pacients with cardiovascular diseases

      ea0029p335
    • Testosterone and androstane-3[alpha], 17[beta]-diol glucuronide correlate with coronary disease

      ea0029p336
    • Cardiovascular function and IGF1 deficit (IGF1-D) in [beta]-thalassemia major

      ea0029p337
    • Psoriasis is associated with decreased adiponectin levels beyond cardiovascular and metabolic risk factors

      ea0029p338
    • The importance of HDL cholesterol to predict adiponectin and retinol binding protein 4 concentration after one session resistance exercise

      ea0029p339
    • Intrinsic myocardial disease in adults with GH deficiency is characterised by subclinical left ventricular longitudinal dysfunction revealed by tissue Doppler

      ea0029p340
    • Paraoxonase, malondialdehyde and lipids in subjects with asymptomatic gallstones

      ea0029p341
    • Cardiac hormones are dual inhibitors of vascular endothelial growth factor and the VEGFR2 receptor

      ea0029p341.1
  • Clinical case reports - Pituitary/Adrenal
  • • Localization of occult adrenal tissue with cosyntropin-stimulated 18F-FDG-PET/CT in a patient with metachronous adrenocortical tumor who presented with persistently elevated SDHEA after bilateral adrenalectomy

      ea0029p342
    • A case of pheochromocytoma which represented multiple myeloma like change

      ea0029p343
    • Reactivation of Takayasu arteritis in two patients with Cushing's disease after normalization of cortisol secretion.

      ea0029p344
    • Delayed presentation of late onset CSF rhinorrhoea following dopamine agonist therapy for giant prolactinoma

      ea0029p345
    • ACTH-dependent Cushing's syndrome secondary to an ectopic source of ACTH/CRH: three clinical cases with different prognosis and outcome

      ea0029p346
    • Hyponatraemia assessment and outcomes in acute medically ill patients

      ea0029p347
    • A clinical case of a 21 years old man with inborn pituitary dystopia

      ea0029p348
    • A case of acromegaly without clear evidence of pituitary adenoma or ectopic GH/GHRH secreting tumors

      ea0029p349
    • Evaluation on clinical application and long term outcomes of microwave endometrial ablation

      ea0029p350
    • Familial central diabetes insipidus due to a novel mutation in exon 3 of the arginine vasopressin gene

      ea0029p351
    • Successful pregnancy during use of octreotide and pegvisomant in an acromegalic patient

      ea0029p352
    • Long-term efficacy and safety of pasireotide in Cushing's disease: a 36-month case report

      ea0029p353
    • Control of acromegaly in an era where it is technically feasible in almost every patient, is by no means invariable even in a specialist unit

      ea0029p354
    • A case of adrenocortical carcinoma with fever of unknown origin and elevated serum IL6 level

      ea0029p355
    • Desmopressin and non steroidal anti-inflammatory drugs: a case report of severe water intoxication during replacement therapy and review of the literature

      ea0029p356
    • Germ cell tumor of the pituitary-hypothalamic region: case series and clinical experience in the Hospital Universitario Virgen del Rocio

      ea0029p357
    • Adrenal venous sampling for two cases with primary pigmented nodular adrenocortical disease

      ea0029p358
    • Cyclic Cushing's syndrome due to occult ectopic ACTH secretion

      ea0029p359
    • Use of tolvaptan for delayed hyponatremia after transsphenoidal surgery for pituitary adenoma: a case report

      ea0029p360
    • Familial isolated pituitary adenoma cases in Hungary

      ea0029p361
    • Hypopituitarism in an adult patient as the first sign of langerhans cell histiocytosis

      ea0029p362
    • A case of cyclic Cushing's syndrome which was induced remission dramatically by dopamine agonist

      ea0029p363
    • Antinociceptive effect of pasireotide on octreotide-resistant acromegaly-related headache

      ea0029p364
    • Giant cystic pheochromocytoma in an asymptomatic man

      ea0029p365
    • Unusual presentation of hypopituitarism

      ea0029p366
    • Rhabdomyolysis and myopathy in Addison's disease: is there a connection?

      ea0029p367
    • Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury

      ea0029p368
    • A rare case of primary tubercular pituitary abscess in a diabetic patient

      ea0029p369
    • Central diabetes insipidus as first sign of progression to accelerated phase in a chronic myeloid leukemia patient

      ea0029p370
    • Contrast-enhanced ultrasound supports diagnosis in a patient with paravesical paraganglioma

      ea0029p371
    • Pituicytoma and meningeoma presenting as suprasellar tumor: case report

      ea0029p372
    • A clinical case report of an successful spontaneous pregnancy in acromegaly

      ea0029p373
    • Childhood onset hypopituitarism and central apnea: looking beyond hormonal replacement

      ea0029p374
    • Cystic pituitary macroadenoma complicated by recurrent mucocoeles: a rare case report

      ea0029p375
    • A patient with TSH-secreting pituitary macroadenoma, after previous thyroid ablation, successfully treated with long-acting octreotide formulation (octreotide-LAR) and transsphenoidal surgery

      ea0029p376
    • Synchronous papillary and medullary thyroid carcinoma in an acromegaly patient

      ea0029p377
    • Pregnancy in an acromegalic woman: a case report

      ea0029p378
    • Acromegaly, primary hyperparathyroidism and renal cell carcinoma

      ea0029p379
    • Late diagnosis of adrenal tuberculosis

      ea0029p380
    • Spontaneous remission of acromegaly due to pituitary apoplexy: case report

      ea0029p381
    • Oligosymptomatic paraganglioma in the setting of neurofibromatosis type 1

      ea0029p382
    • Histiocytosis X-manifested with insipid diabetes clinical case

      ea0029p383
    • A case history as example for diagnostics and treatment of acromegaly: started and ended with pregnancy

      ea0029p384
    • Adrenal neurilemoma

      ea0029p385
    • A case of autoimmune polyglandular syndrome type II presenting with adrenal crisis

      ea0029p386
    • Elephantiasis nostras verrucosa as a presenting cause of Cushings' disease

      ea0029p387
    • Syndrome of inappropriate secretion of antidiuretic hormone in a elderly women affected with herpes zoster infection: a case report

      ea0029p388
    • Hyponatremia and cytolysis as first signs of decompensated pituitary insufficiency: case report

      ea0029p389
    • Acromegaly and pregnancy: two acromegalic patients treated with somatostatin analogues

      ea0029p390
    • Particular course of a case of acromegaly associated with Waldenstrom's macroglobulinaemia

      ea0029p391
    • A case of acromegaly with nephrogenic adenoma of the bladder: a rare association?

      ea0029p392
    • Recovery of prolactin function following spontaneous pregnancy in a patient with Sheehan's syndrome

      ea0029p393
    • Giant macroprolactinoma: recidive after 12 years (case report)

      ea0029p394
    • An uncommon cause of hypoglycaemia: a case report

      ea0029p395
    • Central diabetes insipidus: about two clinical cases

      ea0029p396
    • Macroprolactinomas: therapy compliance (case report)

      ea0029p397
    • Endocrine hypertension due to primary aldosteronism

      ea0029p398
    • Unusual association between pheochromocytoma, adrenocortical nodular hyperplasia and empty sella: case report

      ea0029p399
  • Clinical case reports - Thyroid/Others
  • • New diabetic emergency; acute rhabdomyolysis complicating hyperglycemic hyperosmolar coma successful management and insight into pathogenesis

      ea0029p400
    • Laminopathy and auto-immune sclerodermia: chance or necessity?

      ea0029p401
    • Pendred's syndrome: genetics and phenotypic variability

      ea0029p402
    • A rare case of vanishing fetal goiter and role of colour doppler ultrasound in the diagnosis

      ea0029p403
    • Gastrostomy solves severe hypoglycemias after bariatric surgery

      ea0029p404
    • Pubertal induction with testosterone of a boy with bilateral anorchia guided by the development of his monozygotic twin brother

      ea0029p405
    • Pseudohypoparathyroidism type Ib: a case of occult familial disease

      ea0029p406
    • Considering familial benign hypocalciuric hypercalcemia on differential diagnosis of primary hyperparathyroidism

      ea0029p407
    • The diagnostic challenge of a parathyroid adenoma undetectable by Tc-99m Sestamibi scintigraphy or computed tomography in a patient with newly diagnosed sarcoidosis and hypercalcaemia

      ea0029p408
    • Severe gestational hypothyroidism due to anti-TSH receptor blocking antibodies

      ea0029p409
    • A case of refractory hypoglycemia

      ea0029p410
    • Double jeopardy in pregnancy: a case of autoimmune polyglandular syndrome type 2 in a pregnant patient

      ea0029p411
    • Pseudo malabsorption of levothyroxine

      ea0029p412
    • Vitamin D deficiency and elevation of para-thyroid in Thalassemia minor: a case study

      ea0029p413
    • Study of hormone and thyroid antibodies of auto-immune thyroid disorders

      ea0029p414
    • New insulin receptor mutation in a patient with primary amenorrhea

      ea0029p415
    • Plasmapheresis therapy in a case with recurrent pancraetitis attacks as a consequence of hypertryglyceridemia

      ea0029p416
    • Association of thyroid hormone resistance and hypogonadotropic hypogonadism

      ea0029p417
    • 5-Alpha reductase type 2 deficiency: a case report

      ea0029p418
    • Subacute or hashimoto thyroiditis? a diagnostic dilemma: case report

      ea0029p419
    • True hermaphroditism with a rare 46,XX/47,XXY Klinefelter's mosaicism: a new unique case and review of previous reports

      ea0029p420
    • Genetics of HLA-identical monozygous twins with different manifestations of polyglandular autoimmune syndrome

      ea0029p421
    • Papillary thyroid-type carcinoma arising from struma ovarii: a case report

      ea0029p422
    • Hypothyroidism with extensive pericardial effusion: different therapeutical approaches

      ea0029p423
    • Abstract unavailable

      ea0029p424
    • A case of persistent hypoglycemia in the setting of connective tissue disease

      ea0029p425
    • Successful pregnancy in a patient with biologically inactive LH or partial LHCGR resistance

      ea0029p426
    • Quadruple metachronous malignancy in a single patient with multiple sclerosis: case report

      ea0029p427
    • Hungry bone syndrome in a patient with McCune-Albright syndrome after total thyroidectomy: case report

      ea0029p428
    • A case with thyroid metastasis from small cell lung carcinoma

      ea0029p429
    • Central hypothyroidism following peripheral hyperthyroidism: a brief case report

      ea0029p430
    • Impact of glibenclamide therapy in a patient with neonatal diabetes and intermediate DEND syndrome with the V59M mutation in the KCNJ11 gene

      ea0029p431
    • Parkinson-like syndrom as a unusual manifestation of primary hypoparathyroidism: case report

      ea0029p432
    • Van Wyk e Grumbach syndrome: case report

      ea0029p433
    • Primary hyperparathyroidism associated with autoimmune polyglandular syndrome type III and isolated IgA deficiency

      ea0029p434
    • Reversible Hashimoto's thyroiditis: clinical, hormonal, autoimmune and ultrasonographic evidence

      ea0029p435
    • Hypoparathyroidism - a rare cause of heart failure

      ea0029p436
    • Hypogonadism with subsequent multi-organ involvement: a mystery solved

      ea0029p437
    • Thyrotoxicosis-associated acute myocardial infarction and ventricular fibrillation in a patient with normal epicardial coronary arteries

      ea0029p438
    • A case of papillary thyroid carcinoma with esophageal invasion treated by targeting PEI and transesophageal argon plasma coagulation

      ea0029p439
    • Association between diabetes mellitus and sarcoidosis: a case report

      ea0029p440
    • Noninsulinoma pancreatogenous hypoglycemia syndrome as a rare cause of hyperinsulinemic hypoglycemia: case report

      ea0029p441
    • A case of pneumomediastinum and tracheomalasia in thyroid storm with longstanding goiter

      ea0029p442
    • A case of pancytopenia with hyperthyroidism

      ea0029p443
    • Struma ovarii and the thyroid surgeon

      ea0029p444
    • Multiple myeloma associated with primary hyperparathyroidism

      ea0029p445
    • Graves' disease with a transient lung mass

      ea0029p446
    • Combination of recombinant TSH (rhTSH) and lithium overcomes amiodarone-induced low radioiodine uptake in a thyrotoxic female

      ea0029p447
    • Primary hypoparathyroidism presenting as recurrent TIAs with intracranial calcification

      ea0029p448
    • Ampullary NET presenting as Virchow's node

      ea0029p449
    • Unusual cause of hypokalemic paralysis

      ea0029p450
    • Paraneoplastic severe hyponatremia in a patient with GIST: case report

      ea0029p451
    • Papillary thyroid carcinoma in two patients with primary hyperparathyroidism

      ea0029p452
    • Marked improvement of gastrointestinal pseudo-obstruction after debulking surgery of malignant pheochromocytoma by Intravenous administration of [alpha]-blocker phentolamine

      ea0029p453
    • Primary and secondary hyperparathyroidism coexisting in patient with liver cirrhosis and coeliac disease: efficiency of preoperative treatment with vitamin D

      ea0029p454
    • Primary hyperparathyroidism and metastatic breast cancer: a simultaneous presentation

      ea0029p455
    • Insulinoma presenting as post-prandial hypoglycaemia

      ea0029p456
    • Malignant, ectopic ACTH secreting occult neuroendocrine tumor: a case report

      ea0029p457
    • Noonan Syndrome in adulthood: two cases reports

      ea0029p458
    • Unusual course of Amiodarone-induced hypothyroidism: case report

      ea0029p459
    • Anaplastic thyroid carcinoma: case report

      ea0029p460
    • 'Collision tumor' of the thyroid: a case report

      ea0029p461
    • Unknown reason of continuing hypercalcemia after successful extirpation of parathyroid gland

      ea0029p462
    • Catastrophic bone deformities associated with primary hyperparathyroidism in a middle-aged man

      ea0029p463
    • Severe fetal and neonatal hyperthyroidism following radioiodine therapy in a woman with Graves' disease

      ea0029p464
    • Hypercalcaemia in pregnancy

      ea0029p465
    • Ectopic Cushing's syndrome and thymic hyperplasia

      ea0029p466
    • Synchronous papillary thyroid cancer and astrocytoma: case report

      ea0029p467
    • Exogenous thyrotoxicosis by consumption of pork sausage

      ea0029p468
    • Ovarian hyperstimulation syndrome and autoimmune primary hypothyroidism in two members of a family

      ea0029p469
    • Novel treatment option in the management of SIADH related Hyponatremia: two case reports

      ea0029p470
    • Growth hormone: 'beginning of a new life'

      ea0029p471
    • Severe amiodaron: induced thyrotoxicosis

      ea0029p472
    • Thyreotoxic periodic paralysis in a Caucasian man after corticosteroid administration

      ea0029p473
    • Adrenal crisis due to unusual cause: case report

      ea0029p474
    • Persistently abnormal thyroid function in a 26 year old Afro-Caribbean man: a diagnostically challenging case

      ea0029p475
    • Asymptomatic hypocalcemia in elderly

      ea0029p476
    • Thyroid nodule: dormant, but lethal

      ea0029p477
    • Morbid obesity: what can be and should be done?

      ea0029p478
    • Sever Grave's disease and diabetes melitus

      ea0029p479
    • Secondary hypertension: a case presentation

      ea0029p480
  • Developmental endocrinology
  • • Regulation of trophoblast 11[beta]-hydroxysteroid dehydrogenase type 2 expression and role of corticotropin-releasing hormone

      ea0029p481
    • Dimensional profiles of male to female gender identity disorder: an exploratory research

      ea0029p482
    • GH replacement therapy in patients with primary paediatric brain tumours

      ea0029p483